Page last updated: 2024-08-23

phosphotyrosine and citric acid, anhydrous

phosphotyrosine has been researched along with citric acid, anhydrous in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, S; Azimioara, M; Bartlett, C; Bohacek, R; Cerasoli, F; Dalgarno, D; Guan, W; Haraldson, C; Hatada, M; Herson, J; Iuliucci, J; Lu, X; Merry, T; Metcalf, C; Narula, S; Pradeepan, S; Sawyer, T; Shakespeare, W; Smith, J; Stebbins, K; Sundaramoorthi, R; van Schravendijk, MR; Violette, S; Vu, C; Weigele, M; Yang, M	1
Bohacek, RS; Dalgarno, DC; Hatada, M; Jacobsen, VA; Lynch, BA; Macek, KJ; Merry, T; Metcalf, CA; Narula, SS; Sawyer, TK; Shakespeare, WC; Violette, SM; Weigele, M	1

Other Studies

2 other study(ies) available for phosphotyrosine and citric acid, anhydrous

Article	Year
Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity. Proceedings of the National Academy of Sciences of the United States of America, 2000, Aug-15, Volume: 97, Issue:17 Topics: Adsorption; Amino Acid Substitution; Animals; Binding Sites; Bone and Bones; Bone Resorption; Citric Acid; Crystallography, X-Ray; Dentin; Diphosphonates; Drug Design; Female; Hydroxyapatites; Inhibitory Concentration 50; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Models, Molecular; Molecular Mimicry; Osteoclasts; Parathyroid Hormone; Parathyroidectomy; Phosphotyrosine; Protein Conformation; Proto-Oncogene Proteins pp60(c-src); Rabbits; Rats; Rats, Wistar; src Homology Domains; Structure-Activity Relationship; Substrate Specificity	2000
X-Ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor. Journal of medicinal chemistry, 2001, Mar-01, Volume: 44, Issue:5 Topics: Animals; Benzamides; Bone and Bones; Bone Resorption; Citric Acid; Crystallography, X-Ray; Cyclohexanes; Durapatite; Enzyme Inhibitors; Ligands; Models, Molecular; Molecular Mimicry; Organophosphorus Compounds; Osteoclasts; Phosphotyrosine; Protein Binding; Proto-Oncogene Proteins pp60(c-src); Rabbits; src Homology Domains	2001

Article

Year

Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity.

Proceedings of the National Academy of Sciences of the United States of America, 2000, Aug-15, Volume: 97, Issue:17

Topics: Adsorption; Amino Acid Substitution; Animals; Binding Sites; Bone and Bones; Bone Resorption; Citric Acid; Crystallography, X-Ray; Dentin; Diphosphonates; Drug Design; Female; Hydroxyapatites; Inhibitory Concentration 50; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Models, Molecular; Molecular Mimicry; Osteoclasts; Parathyroid Hormone; Parathyroidectomy; Phosphotyrosine; Protein Conformation; Proto-Oncogene Proteins pp60(c-src); Rabbits; Rats; Rats, Wistar; src Homology Domains; Structure-Activity Relationship; Substrate Specificity

2000

X-Ray structure of citrate bound to Src SH2 leads to a high-affinity, bone-targeted Src SH2 inhibitor.

Journal of medicinal chemistry, 2001, Mar-01, Volume: 44, Issue:5

Topics: Animals; Benzamides; Bone and Bones; Bone Resorption; Citric Acid; Crystallography, X-Ray; Cyclohexanes; Durapatite; Enzyme Inhibitors; Ligands; Models, Molecular; Molecular Mimicry; Organophosphorus Compounds; Osteoclasts; Phosphotyrosine; Protein Binding; Proto-Oncogene Proteins pp60(c-src); Rabbits; src Homology Domains

2001